scholarly journals Ultrasound, macroscopic and histological features of malignant ovarian tumors. Metastatic tumors to the ovary: ovarian metastases from biliary tract and ovarian metastases from colon cancer

2021 ◽  
Vol 31 (10) ◽  
pp. 1388-1390
Author(s):  
Francesca Ciccarone ◽  
Claudia Codecà ◽  
Valeria Versace ◽  
Francesca Moro
Keyword(s):  
Colon Cancer ◽  
Biliary Tract ◽  
Ovarian Tumors ◽  
Metastatic Tumors ◽  
Ovarian Metastases ◽  
Histological Features

Simultaneous carcinoma of the endometrium and ovary vs. endometrial carcinoma with ovarian metastases: A clinical and immunohistochemical determination

2003 ◽  
Vol 13 (1) ◽  
pp. 32-37
Author(s):  
L. Habler ◽  
R. Halperin ◽  
S. Zehavi ◽  
E. Hadas ◽  
I. Bukovsky ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Endometrial Carcinoma ◽  
Familial Cancer ◽  
Immunohistochemical Analysis ◽  
Ovarian Tumors ◽  
Immunohistochemical Expression ◽  
Metastatic Tumors ◽  
Ki 67 ◽  
Ovarian Metastases ◽  
Her 2

The aim of this study was to perform a clinical and immunohistochemical comparison between simultaneous independent tumors involving endometrium and ovary and metastatic endometrial tumors, and to try to find clinical and /or immunohistochemical parameters differentiating between these two entities. Sixteen cases of simultaneous independent primaries of endometrium and ovary, presenting the same histologic type, were compared with 12 cases of primary endometrial cancer, demonstrating ovarian metastases. The comparison related to patients' characteristics and immunohistochemical expression of estrogen and progesterone receptors (ER,PR), bcl-2, HER-2 /neu, p53, and cell proliferation marker Ki-67 in endometrial and ovarian tumors.The only clinical parameter differentiating significantly between the groups was the prevalence of familial cancer, being more frequent in the group of metastatic tumors (P = 0.03). Immunohistochemical analysis demonstrated the same immunostaining in endometrium and ovary for all immunohistochemical parameters in cases of metastatic endometrial cancer. Conversely, 62.5% of cases with simultaneous tumors of endometrium and ovary could be differentiated from metastatic tumors by distinct immunohistochemical expression of ER and PR in endometrial and ovarian tumors (P = 0.0006), and 31.3% of cases could be differentiated by distinct immunostaining for bcl-2 (P = 0.03). Immunohistochemical parameters HER–2 /neu, p53 and Ki-67 were not appropriate for the distinction between the two study groups. We conclude that the application of immunohistochemical analysis may play an important role in the differentiation between cases of simultaneous independent carcinomas of endometrium and ovary vs. cases of endometrial carcinoma with ovarian metastases.

scholarly journals Influence of the primary malignant tumor site on the incidence and features of metastatic ovarian tumors

2007 ◽  
Vol 64 (10) ◽  
pp. 691-696 ◽  
Author(s):  
Zorica Stanojevic ◽  
Biljana Djordjevic ◽  
Danijela Zivanovic
Keyword(s):  
Malignant Tumor ◽  
Malignant Tumors ◽  
Statistical Significance ◽  
Menopausal Status ◽  
Ovarian Tumors ◽  
Metastatic Tumors ◽  
Primary Tumors ◽  
Primary Malignant Tumor ◽  
Group A ◽  
Group B

Background/Aim. Ovary is the organ of the female reproductive system most commonly affected by metastases. The aim of the study was to determine the frequency and features of metastatic ovarian tumors (MOT) depending on the site of the primary malignant tumor. Methods. The study group consisted of 488 patients with histopathologically confirmed ovarian cancers treated at the Clinic of Oncology, Clinical Center Nis, in the period from 1 January 1998 to 31 December 2005. MOT were found in 41 patients. Regarding the site of the primary malignant tumor, those with secondary ovarian tumor were divided into two groups: group A - primary malignant tumor involving the genital organs (n = 30) and group B - primary malignant tumor of extragenital origin (n = 11). Results. MOT were confirmed in 8.40% (41/488) of the patients. Secondary ovarian malignancies were the consequence of endometrial carcinoma spreading in 73.17%, breast carcinoma in 19.51%, stomach carcinoma in 4.88% and colon carcinoma in 2.44% of the cases. No significant differences were found between the group A and group B by the factors of age, body mass index, parity and menopausal status. Contrary to the group A, metastatic tumors in the group B patients were more commonly asymptomatic (p < 0.001), bilateral (p < 0.05), with larger ovarian diameter (p < 0.05), associated with ascites (p < 0.001) and abdominal metastases (p < 0.01), all of statistical significance. Conclusions. Metastatic tumors made up 8.40% of ovarian neoplasmas. With non-genital primary tumors, secondary ovarian deposits were frequently asymptomatic, bilateral, associated with larger ovarian diameter, ascites and abdominal metastatic deposits, compared to malignant tumors of genital origin.

Computed Tomography Findings of Ovarian Metastases From Colon Cancer

2005 ◽  
Vol 29 (1) ◽  
pp. 69-73 ◽  
Author(s):  
Hyuck Jae Choi ◽  
Joo-Hyuk Lee ◽  
Sang-Soo Seo ◽  
Sun Lee ◽  
Seok Ki Kim ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Colon Cancer ◽  
Ovarian Metastases

Histological features of lymph node metastasis in patients with biliary tract cancer

2008 ◽  
Vol 97 (5) ◽  
pp. 423-427 ◽  
Author(s):  
Haruki Morimoto ◽  
Tetsuo Ajiki ◽  
Takashi Ueda ◽  
Hidehiro Sawa ◽  
Tsunenori Fujita ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Histological Features ◽  
Tract Cancer ◽  
Node Metastasis

Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand

2006 ◽  
Vol 16 (Suppl 1) ◽  
pp. 132-138 ◽  
Author(s):  
S. Khunamornpong ◽  
P. Suprasert ◽  
W. Na Chiangmai ◽  
S. Siriaunkgul
Keyword(s):  
Bile Duct ◽  
Extrahepatic Bile Duct ◽  
Intrahepatic Bile Duct ◽  
Gestational Trophoblastic Disease ◽  
Ovarian Tumors ◽  
University Hospital ◽  
Unknown Primary ◽  
Metastatic Tumors ◽  
Northern Thailand ◽  
Radiologic Findings

The cases of malignant ovarian tumors treated at Chiang Mai University hospital between 1992 and 2003 were histologically reviewed. The medical records, the radiologic findings, and the follow-up outcome in the cases suspicious or diagnostic of metastases were reviewed to confirm the diagnosis and to determine the primary sites. Metastatic tumors accounted for 30% of malignant ovarian tumors. A total of 170 cases of metastatic tumors included 117 cases with nongynecologic origin and 53 cases with gynecologic origin. Nongynecologic metastatic tumors were from large intestine (31%), stomach (14%), intrahepatic bile duct (10%), breast (9%), extrahepatic bile duct/gallbladder (7%), appendix (5%), hematologic tumors (3%), others (4%), and unknown primary site (16%). Metastatic gynecologic tumors were from cervix (53%), corpus (34%), fallopian tube (11%), and gestational trophoblastic disease (2%). The proportion of metastatic tumors to malignant ovarian tumors in northern Thailand was comparable to those of the Western or Japanese studies. However, the distribution of the primary sites was different and was correlated with the cancer incidence in Thai women. The majority of mucin-producing adenocarcinomas involving the ovaries were metastatic tumors.

Manifestation of Bilateral Huge Ovarian Metastases from Colon Cancer Immediately After the Initial Operation: Report of a Case

Surgery Today ◽  
2002 ◽  
Vol 32 (4) ◽  
pp. 371-375 ◽  
Author(s):  
Chouhei Sakakura ◽  
Akeo Hagiwara ◽  
Dai Kato ◽  
Takuo Hamada ◽  
Hisakazu Yamagishi
Keyword(s):  
Colon Cancer ◽  
Initial Operation ◽  
Ovarian Metastases

scholarly journals Pancreatic Cancer With Ovarian Metastasis: Clinical Features, Diagnosis and Management

2020 ◽  
Author(s):  
Xingtong Zhou ◽  
Hongtao Cao ◽  
Banbo Zhao ◽  
Zhibo Zheng ◽  
Cheng Qin ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Clinical Features ◽  
Elevated Serum ◽  
Ovarian Metastasis ◽  
The Body ◽  
Ovarian Tumors ◽  
Pancreatic Tumors ◽  
Pancreatic Metastasis ◽  
Ovarian Metastases ◽  
Diagnosis And Management

Abstract Background: To summarize the clinical features, diagnosis and management of pancreatic cancer with ovarian metastasis.Methods: We retrospectively analyzed the clinical data of patients with ovarian metastases of primary pancreatic cancer who were admitted to our hospital from 01/01/1985 to 04/01/2020.Results: In total, there were 3757 female pancreatic-cancer patients. 9 of them were diagnosed with ovarian metastasis at an average age of 51.89 (38-69) years. The reason for the patients’ visit was generally a mass in the lower abdomen and/or abdominal pain. 7 patients had significantly higher serum CA19-9 levels. 8 patients had pancreatic tumors located in the body or tail; 1 patient, in the pancreatic head. All patients underwent excision of ovarian tumors and resection or biopsy of pancreatic tumors. 6 patients had pancreatic ductal adenocarcinoma (PDAC), 2 had pancreatic cystadenocarcinoma (PCC), and 1 had pancreatic neuroendocrine carcinoma (PNEC), all revealed by the pathological results. Ovarian tumors were assessed by pathology and were consistent with pancreatic metastasis. Currently, 2 patients are still alive (followed until 04/2020). The median survival time for all patients was 7 months (2.9-22 months).Conclusions: Pancreatic cancer with ovarian metastases is rare and easily misdiagnosed. When ovarian tumors are suspected to be metastatic, elevated serum CA19-9 may indicate that the primary cancer is pancreatic. Enhanced CT can facilitate diagnostic localization. In addition, if the pancreatic tumor cannot be removed, the ovarian tumor should still be resected to reduce the tumor load and improve quality of life.

Sign in / Sign up

Export Citation Format

Share Document